Product Development

CMC Manufacturing Strategy and Operations

Strategies designed for operational success

We provide strategic guidance on the stages and costs of biopharmaceutical drug development including potency methods, such as binding assays and bioassays.

Our full spectrum of strategy and operations support features solutions tailored to your business. Our dedicated team can:
  • Develop budget and timeline estimates for preclinical development
  • Design preclinical proof-of-concept studies
  • Create manufacturing processes and oversee implementation
  • Support assay development and qualification
  • Plan and oversee execution of formulation development and stability
  • Manage reference standard preparation
  • Oversee production of toxicology and cGMP lots
  • Plan and execute GLP toxicology studies

Why choose Alira Health?

From engagement to product launch, you can rely on a dedicated Alira Health team to support the full spectrum of your drug development needs:

  • Knowledgeable industry experts who deliver scalable, actionable insights
  • Commitment to client advocacy with vendors to drive holistic solutions tailored to your business needs and goals
  • Focus on identification and execution of phase-appropriate clinical development activities
  • Strategic technical guidance, risk management, and evaluation of costs for clinical and commercial manufacturing development processes

Related news

Research & Development
Events October 5, 2021
Event: STEM Week – Life Sciences Jobs: Demystifying Career Paths 101
Join the MetroWest STEM Education Network is delighted to host a special panel discussion for Massachusetts STEM Week 2021.
Due Diligence Research & Development
Publications August 18, 2021
Infographic: Indication Prioritization and Pre-Commercial Value Assessment
Download our infographic on Indication Prioritization and Pre-Commercial Value Assessment.
Pharma Research & Development
Publications August 2, 2021
Infographic: Prioritization Strategy of R&D Targets for Biotech Company
Download our infographic on Prioritization Strategy of R&D Targets for Biotech Company
Research & Development
Publications June 9, 2021
EU Supply Integrity Guidelines
Check out Alira Health's latest publication, “EU Supply Integrity Guidelines”. In the document, best practices for European distribution and supply integrity management are highlighted(...)
Research & Development
Publications May 27, 2021
Buffers – Navigating New Demands On Downstream Raw Materials
The COVID-19 pandemic has put unusual pressures on the supply and demand of raw materials required for the production and purification of biologics. A specific concern for the biomanufacturing(...)
Research & Development
Publications April 26, 2021
Recombinant Human Polyclonal Antibodies to Treat Disease
Congratulations to Alira Health’s Steven Chamow, PhD, Senior Vice President, CMC and founder of Chamow & Associates, and to Bryan Monroe and Chuck Olson, Senior Consultants, on their(...)
Research & Development
News March 15, 2021
Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical
BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce that Nikole Siegmund has joined the firm(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.